[HTML][HTML] Medicating patients during extracorporeal membrane oxygenation: the evidence is building

AL Dzierba, D Abrams, D Brodie - Critical Care, 2017 - Springer
This article is one of ten reviews selected from the Annual Update in Intensive Care and
Emergency Medicine 2017. Other selected articles can be found online at http://ccforum …

[HTML][HTML] Optimizing antimicrobial drug dosing in critically ill patients

P Póvoa, P Moniz, JG Pereira, L Coelho - Microorganisms, 2021 - mdpi.com
A fundamental step in the successful management of sepsis and septic shock is early
empiric antimicrobial therapy. However, for this to be effective, several decisions must be …

Evaluation of altered drug pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation

MA Ha, AC Sieg - … : The Journal of Human Pharmacology and …, 2017 - Wiley Online Library
Extracorporeal membrane oxygenation (ECMO) is a life‐support modality used in patients
with refractory cardiac and/or respiratory failure. A significant resurgence in the use ECMO …

Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review

AS Alobaid, M Hites, J Lipman, FS Taccone… - International journal of …, 2016 - Elsevier
The increased prevalence of obesity presents challenges for clinicians aiming to provide
optimised antimicrobial dosing in the intensive care unit. Obesity is likely to exacerbate the …

[HTML][HTML] Nanosilver: An old antibacterial agent with great promise in the fight against antibiotic resistance

KG Kaiser, V Delattre, VJ Frost, GW Buck, JV Phu… - Antibiotics, 2023 - mdpi.com
Antibiotic resistance in bacteria is a major problem worldwide that costs 55 billion USD
annually for extended hospitalization, resource utilization, and additional treatment …

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …

Colistin population pharmacokinetics after application of a loading dose of 9 MU colistin methanesulfonate in critically ill patients

I Karaiskos, LE Friberg, K Pontikis… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Colistin has been revived, in the era of extensively drug-resistant (XDR) Gram-negative
infections, as the last-resort treatment in critically ill patients. Recent studies focusing on the …

[HTML][HTML] Aminoglycosides for the treatment of severe infection due to resistant gram-negative pathogens

M Thy, JF Timsit, E de Montmollin - Antibiotics, 2023 - mdpi.com
Aminoglycosides are a family of rapidly bactericidal antibiotics that often remain active
against resistant Gram-negative bacterial infections. Over the past decade, their use in …

[HTML][HTML] Clinical pharmacokinetics of gentamicin in various patient populations and consequences for optimal dosing for gram-negative infections: an updated review

CJ Hodiamont, AK van den Broek, SL de Vroom… - Clinical …, 2022 - Springer
Gentamicin is an aminoglycoside antibiotic with a small therapeutic window that is currently
used primarily as part of short-term empirical combination therapy. Gentamicin dosing …

[HTML][HTML] Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal …

JA Roberts, R Bellomo, MO Cotta, BCP Koch… - Intensive Care …, 2022 - Springer
Intensive care unit (ICU) patients with end-organ failure will require specialised machines or
extracorporeal therapies to support the failing organs that would otherwise lead to death …